Finance

Lists
DRTS:NASDAQ
Alpha Tau Medical Ltd
$14.47
+1.47%
(+0.21) 1D
$14.46
-0.07% (-0.010)
After hours
Closed: Aug 19, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DRTS...
Open
$14.52
High
$14.70
Low
$14.17
Mkt. cap
1.37B
Avg. vol.
570.56K
Volume
67.00
52-wk high
$14.75
52-wk low
$3.03
EPS
-$0.66
Beta
1.17
Shares outstanding
88.01M
No. of employees
121
Open
$14.52
High
$14.70
Low
$14.17
Mkt. cap
1.37B
Avg. vol.
570.56K
Volume
67.00
52-wk high
$14.75
52-wk low
$3.03
EPS
-$0.66
Beta
1.17
Shares outstanding
88.01M
No. of employees
121
News stories
From web sources and news partners
About Alpha Tau Medical Ltd
CEO-
Employees121
Founded2015
Headquarters-
SectorMedical device
Websitealphatau.com
Analyst ratings
Based on 3 analysts giving stock ratings to DRTS in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DRTS in the last 3 months.
Highest
Current $14.47
$17.00 (+17.48%)
Average
$13.67 (-5.53%)
Lowest
$8.00 (-44.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
$16.00
+10.6%
08/12/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
$8.00
-44.7%
08/11/2026
Lukas Shumway
Barclays
Buy
Maintained
$17.00
+17.5%
08/11/2026
Unknown Analyst
Barclays
Buy
Initiated
$15.00
+3.7%
05/28/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Reiterated
$14.00
-3.2%
05/12/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
$9.00
-37.8%
03/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.31M
9.58M
10.98M
9.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.42M
3.03M
2.34M
3.88M
Operating expense
10.73M
12.60M
13.31M
13.78M
Total operating expenses
10.73M
12.60M
13.31M
13.78M
Operating income
-10.73M
-12.60M
-13.31M
-13.78M
Other non operating income
475.00K
-2.09M
-
-42.20M
EBT including unusual items
-11.69M
-12.17M
-22.95M
-45.58M
EBT excluding unusual items
-11.69M
-12.17M
-22.95M
-45.58M
Income tax expense
-8.00K
-35.00K
-11.00K
229.00K
Effective tax rate
0.07%
0.29%
0.05%
-0.50%
Other operating expenses
-
-
-
-
Net income
-11.69M
-12.14M
-22.94M
-45.81M
Net profit margin
-
-
-
-
Earnings per share
-0.14
-0.14
-0.26
-0.50
Interest and investment income
-
4.14M
-
11.36M
Interest expense
-2.34M
-
-9.64M
-
Net interest expenses
-2.34M
4.14M
-9.64M
11.36M
Depreciation and amortization charges
-
-
-
-
EBITDA
-10.45M
-12.29M
-13.00M
-13.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps